NASDAQ: HRTXHeron Therapeutics Revenue
Heron Therapeutics revenue was $148.52M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $38.9M, down 4.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, HRTX annual revenue was $144.3M, with 13.6% growth year-over-year.
HRTX past revenue growth
How has HRTX's revenue growth performed historically?
Company
12.43%
Industry
149.28%
Market
19.57%
HRTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
HRTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
HRTX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
HRTX revenue history
Current Revenue
$148.5M
Current Earnings
-$7.8M
Current Profit Margin
-5.2%
Be the first to know when HRTX announces revenue.
HRTX Revenue History By Year
| HRTX Yearly Revenue | HRTX Revenue | HRTX Change | HRTX Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $144.29M | $17.24M | +13.57% |
| 2023-12-31 | $127.04M | $19.37M | +17.99% |
| 2022-12-31 | $107.67M | $21.33M | +24.70% |
| 2021-12-31 | $86.35M | -$2.29M | -2.59% |
| 2020-12-31 | $88.64M | -$57.33M | -39.28% |
| 2019-12-31 | $145.97M | $68.49M | +88.41% |
| 2018-12-31 | $77.47M | $46.71M | +151.81% |
| 2017-12-31 | $30.77M | $29.49M | +2,305.55% |
| 2016-12-31 | $1.28M | N/A | N/A |
| 2015-12-31 | $0.00 | N/A | N/A |
| 2014-12-31 | $0.00 | N/A | N/A |
| 2013-12-31 | $0.00 | N/A | N/A |
| 2012-12-31 | $0.00 | -$646.00k | -100.00% |
| 2011-12-31 | $646.00k | -$655.00k | -50.35% |
| 2010-12-31 | $1.30M | $40.00k | +3.17% |
| 2009-12-31 | $1.26M | $892.00k | +241.73% |
| 2008-12-31 | $369.00k | -$43.00k | -10.44% |
| 2007-12-31 | $412.00k | N/A | N/A |
| 2006-12-31 | $0.00 | -$5.39M | -100.00% |
| 2005-12-31 | $5.39M | -$13.00k | -0.24% |
| 2004-12-31 | $5.40M | $556.00k | +11.47% |
| 2003-12-31 | $4.85M | $178.00k | +3.81% |
| 2002-12-31 | $4.67M | $1.41M | +43.03% |
| 2001-12-31 | $3.27M | -$101.00k | -3.00% |
| 2000-12-31 | $3.37M | -$1.33M | -28.33% |
| 1999-12-31 | $4.70M | $1.62M | +52.77% |
| 1998-12-31 | $3.07M | -$14.13M | -82.13% |
| 1997-12-31 | $17.21M | -$453.96k | -2.57% |
| 1996-12-31 | $17.66M | $1.55M | +9.64% |
| 1995-12-31 | $16.11M | $223.75k | +1.41% |
| 1994-12-31 | $15.88M | N/A | N/A |
Heron Therapeutics Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.